This evaluation assesses the degree of implementation of the EU Drugs Strategy 2013- 2020 and the Action Plan 2013-2016 in terms of outputs and, to the extent possible, impacts. It looks at the extent to which the objectives of the EU Drugs Strategy have been achieved, highlighting the areas...

In accordance with the Better Regulation guidelines a mandatory public consultation was conducted to inform the Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and the final evaluation of the EU Action Plan on Drugs 2013-2016. The consultation was launched on 15 February 2016 on the...

Drug law enforcement is likely to be the intervention that contributes the most to reducing the supply of drugs in Europe. Important statistical datasets on drug seizures and drug law offences are the result of drug law enforcement activity, yet little is known about how drug law enforcement is...

This brochure contains the full text of the EU Drugs Strategy for 2013-2020. The strategy provides the political framework and priorities for EU drugs policy identified by Member States and EU institutions. The strategy's aims include contributing to a reduction in drug demand and supply within...

The EU Drugs Strategy 2013-2020 was adopted in December 2012 and sets out the vision and aims of the European Union's drug policy. The Strategy is organised around two policy fields (drug demand and supply reduction) and three cross-cutting themes (coordination, international cooperation, and...

Mindful of a number of issues, it looked as if the 54th CND would be an intriguing event. Held in Vienna between 21-25 March, the Commission would be the first for the new Executive Director of the United Nations Office on Drugs and Crime (UNODC), Mr. Yury Fedotov. It was also the first meeting...

One of the barriers to drug policy analysis and reform is uncertainty as to the effects of possible policy changes (Shanahan & Ritter, 2012). This paper will use datafrom the Global Drug Survey to examine potential effects of policy changes in both the UK and Australian drug markets, based on...

In 2014, the EMCDDA took the decision to carry out a limited follow-up study of the EMCDDA Paper Drug squads: units specialised in drug law enforcement in Europe (EMCDDA, 2013), with the aim of monitoring possible changes and trends in drug supply reduction resulting from law enforcement...

Comparable and reliable data about the number and characteristics of people entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatment entrants through the Treatment demand indicator...